Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Revvity Inc (RVTY)

Revvity Inc (RVTY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,067,765
  • Shares Outstanding, K 113,376
  • Annual Sales, $ 2,856 M
  • Annual Income, $ 241,200 K
  • EBIT $ 357 M
  • EBITDA $ 767 M
  • 60-Month Beta 1.07
  • Price/Sales 3.86
  • Price/Cash Flow 11.02
  • Price/Book 1.52

Options Overview Details

View History
  • Implied Volatility 45.19% (+0.85%)
  • Historical Volatility 43.81%
  • IV Percentile 88%
  • IV Rank 50.09%
  • IV High 63.49% on 10/20/25
  • IV Low 26.84% on 06/17/25
  • Expected Move (DTE 23) 7.05 (7.30%)
  • Put/Call Vol Ratio 0.07
  • Today's Volume 15
  • Volume Avg (30-Day) 91
  • Put/Call OI Ratio 0.43
  • Today's Open Interest 1,433
  • Open Int (30-Day) 1,826
  • Expected Range 89.51 to 103.61

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.02
  • Number of Estimates 8
  • High Estimate 1.04
  • Low Estimate 1.01
  • Prior Year 1.01
  • Growth Rate Est. (year over year) +0.99%

Price Performance

See More
Period Period Low Period High Performance
1-Month
93.70 +2.80%
on 02/12/26
118.21 -18.52%
on 01/26/26
-20.41 (-17.48%)
since 01/23/26
3-Month
93.70 +2.80%
on 02/12/26
118.30 -18.58%
on 01/22/26
-9.25 (-8.76%)
since 11/25/25
52-Week
81.36 +18.39%
on 09/04/25
120.39 -19.99%
on 03/10/25
-19.17 (-16.60%)
since 02/25/25

Most Recent Stories

More News
Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know

Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know

MEDP : 437.84 (-0.99%)
TECH : 58.01 (+0.71%)
OSCR : 12.97 (+5.45%)
AZTA : 28.32 (+0.50%)
RVTY : 96.93 (-0.71%)
Do Wall Street Analysts Like Revvity Stock?

Although Revvity has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

XLV : 157.74 (-0.08%)
$SPX : 6,942.16 (+0.76%)
RVTY : 96.93 (-0.71%)
3 Healthcare Stocks Walking a Fine Line

3 Healthcare Stocks Walking a Fine Line

RPRX : 45.36 (-0.09%)
MTD : 1,385.55 (+0.43%)
RVTY : 96.93 (-0.71%)
Revvity to Present at Upcoming Investor Conferences

Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences: Raymond James 47 th Annual Institutional Investors Conference...

RVTY : 96.93 (-0.71%)
3 Unpopular Stocks We Think Twice About

3 Unpopular Stocks We Think Twice About

THO : 102.95 (-5.13%)
DBRG : 15.38 (-0.06%)
RVTY : 96.93 (-0.71%)
Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026

New launches in high-content imaging, detection, and automation help labs accelerate drug discovery workflows from sample to insight

RVTY : 96.93 (-0.71%)
Revvity’s (NYSE:RVTY) Q4 CY2025 Sales Beat Estimates

Revvity’s (NYSE:RVTY) Q4 CY2025 Sales Beat Estimates

RVTY : 96.93 (-0.71%)
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2025

Fourth quarter revenue of $772 million; 6% revenue growth; 4% organic growth Fourth quarter GAAP EPS of $0.87; Adjusted EPS from continuing operations...

RVTY : 96.93 (-0.71%)
Revvity (RVTY) Q4 Earnings: What To Expect

Revvity (RVTY) Q4 Earnings: What To Expect

RVTY : 96.93 (-0.71%)
Revvity Board Declares Quarterly Dividend

The Board of Directors of Revvity, Inc. (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on May 8, 2026 to all shareholders...

RVTY : 96.93 (-0.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software,...

See More

Key Turning Points

3rd Resistance Point 101.37
2nd Resistance Point 100.43
1st Resistance Point 99.02
Last Price 96.93
1st Support Level 96.67
2nd Support Level 95.73
3rd Support Level 94.32

See More

52-Week High 120.39
Fibonacci 61.8% 105.48
Fibonacci 50% 100.88
Last Price 96.93
Fibonacci 38.2% 96.27
52-Week Low 81.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar